Verrica Pharmaceuticals (VRCA) Q3 2024 Earnings

14AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.56
-0.48
-0.4
-0.32

Details

Expected EPS
-0.41385
Actual EPS
-0.37
Surprise EPS
0.04
Surprise Percent
+10.6%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.37 per share for Q3 2024.

0 Comments

Share your thoughts